Følg
Borivoj Galić
Borivoj Galić
Verifisert e-postadresse på pmf.unsa.ba
Tittel
Sitert av
Sitert av
År
Advantages of an electrochemical method compared to the spectrophotometric kinetic study of peroxidase inhibition by boroxine derivative
J Ostojić, S Herenda, Z Bešić, M Miloš, B Galić
Molecules 22 (7), 1120, 2017
652017
Dipotassium-trioxohydroxytetrafluorotriborate, K2[B3O3F4OH], is a potent inhibitor of human carbonic anhydrases
D Vullo, M Milos, B Galic, A Scozzafava, CT Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry 30 (2), 341-344, 2015
362015
A study of the inhibition of catalase by dipotassium trioxohydroxytetrafluorotriborate K2 [B3O3F4OH]
S Islamovic, B Galic, M Milos
Journal of enzyme inhibition and medicinal chemistry 29 (5), 744-748, 2014
332014
In vitro and in vivo antitumor activity of the halogenated boroxine dipotassium-trioxohydroxytetrafluorotriborate (K2 [B3O3F4OH])
S Ivankovic, R Stojkovic, Z Galic, B Galic, J Ostojic, M Marasovic, M Milos
Journal of enzyme inhibition and medicinal chemistry 30 (3), 354-359, 2015
302015
Effects of dipotassium trioxohydroxytetrafluorotriborate (K2[B3O3F4OH]) on genetic material and inhibition of cell division in human cell cultures
S Haveric, A Haveric, K Bajrovic, B Galic, M Maksimovic
Drug and Chemical Toxicology 34 (3), 250-254, 2011
252011
In vitro and in vivo antitumour effects of phenylboronic acid against mouse mammary adenocarcinoma 4T1 and squamous carcinoma SCCVII cells
M Marasovic, S Ivankovic, R Stojkovic, D Djermic, B Galic, M Milos
Journal of enzyme inhibition and medicinal chemistry 32 (1), 1299-1304, 2017
202017
Boroxine composition for removal of skin changes
B Galic
US Patent 8,278,289, 2012
192012
Inhibitory effects of delphinidin and luteolin on genotoxicity induced by K2B3O3F4OH) in human lymphocytes in vitro
M Hadžić, S Haverić, A Haverić, B Galić
Biologia 70, 553-558, 2015
182015
Inhibition of Horseradish Peroxidase Activity by Boroxine Derivative, Dipotassium‐trioxohydroxytetrafluorotriborate K2[B3O3F4OH]
J Ostojic, S Herenda, S Galijasevic, B Galic, M Milos
Journal of Chemistry 2017 (1), 8134350, 2017
152017
Electrochemical investigation of the influence of K2 [B3O3F4OH] on the activity of immobilized superoxide dismutase
S Herenda, J Ostojić, E Hasković, D Hasković, M Miloš, B Galić
International journal of electrochemical science 13 (4), 3279-3287, 2018
142018
Effects of dipotassium-trioxohydroxytetrafluorotriborate, K2[B3O3F4OH], on cell viability and gene expression of common human cancer drug targets in a …
L Pojskic, S Haveric, N Lojo-Kadric, M Hadzic, A Haveric, Z Galic, B Galic, ...
Journal of enzyme inhibition and medicinal chemistry 31 (6), 999-1004, 2016
132016
Impact of calcium ion on cytotoxic effect of the boroxine derivative, K2[B3O3F4OH]
S Ivankovic, R Stojkovic, M Maksimovic, B Galic, M Milos
Journal of enzyme inhibition and medicinal chemistry 31 (sup3), 70-74, 2016
122016
Bioflavonoids protect cells against halogenated boroxine-induced genotoxic damage by upregulation of hTERT expression
M Hadzic, S Haveric, A Haveric, N Lojo-Kadric, B Galic, J Ramic, L Pojskic
Zeitschrift für Naturforschung C 74 (5-6), 125-129, 2019
92019
Biochemical and histomorphological findings in Swiss Wistar rats treated with potential boron-containing therapeutic-K2 [B3O3F4OH]
A Haverić, A Durmić-Pašić, A Alić, I Mujezinović, A Smajlović, J Ostojić, ...
Journal of Trace Elements in Medicine and Biology 62, 126642, 2020
72020
Genotoxicity Evaluation of Dipotassium -Trioxohydroxytetrafluorotriborate, K2(B3O3F4OH), in Human Lymphocyte Cultures and Mice Reticulocytes
S Haveric, M Hadzic, A Haveric, M Mijanovic, R Hadziselimovic, B Galic
Brazilian Archives of Biology and Technology 59 (00), e16160195, 2016
72016
Halogenated boroxine dipotassium trioxohydroxytetrafluorotriborate K2[B3O3F4OH] inhibits emerging multidrug-resistant and β-lactamase-producing …
A Maravić, T Rončević, L Krce, N Ilić, B Galić, V Čulić Čikeš, I Carev
Drug development and industrial pharmacy 45 (11), 1770-1776, 2019
62019
Novel boron‐containing compound, halogenated boroxine, induces selective cytotoxicity through apoptosis triggering in UT‐7 leukemia
M Hadzic, L Pojskic, N Lojo‐Kadric, A Haveric, J Ramic, B Galic, ...
Journal of Biochemical and Molecular Toxicology 36 (5), e23005, 2022
52022
Quantum Chemical and Biochemical Study on Antioxidant Properties of Halogenated Boroxine K2[B3O3F4OH]
M Marasović, T Marasović, B Galić, M Miloš
Croatica chemica acta 90 (2), 155-161, 2017
32017
IN VITRO STUDY OF THE ANTI-PROLIFERATIVE EFFECTS OF DIPOTASSIUM-TRIOXOHYDROXYTETRAFLUOROTRIBORATE ON THE H520 NON-SMALL CELL LUNG CANCER CELL LINE
J Liu, E Phan, O Saračević, MS Burnett, N Lojo-Kadrić, A Haverić, B Galić
Genetics & Applications 1 (2), 2-7, 2017
22017
Inhibition of Horseradish Peroxidase Activity by Boroxine Derivative, Dipotassium-trioxohydroxytetrafluorotriborate K2 [B3O3F4OH]
J Ostojić, S Herenda, S Galijasević, B Galic, M Mladen
Journal of Chemistry (Hindawi) 2017, 1-7, 2017
22017
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20